$GENE OSCIENT PHARMACEUTICALS CORP Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in OSCIENT PHARMACEUTICALS CORP.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in OSCIENT PHARMACEUTICALS CORP. Insider overview, share value development, latest insider transactions and email notifications about new events in OSCIENT PHARMACEUTICALS CORP for free.

CIK Number: 0000356830
IRS Number: 042297484
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: GENE
Company Address: 1000 WINTER STREET SUITE 2200 WALTHAM 02451
Former name: COLLABORATIVE RESEARCH INC, date of change: 1992-07-03
Former name: GENOME THERAPEUTICS CORP, date of change: 1994-12-15

Genetic Technologies Ltd. is a molecular diagnostics company that offers predictive testing and assessment tools to help physicians proactively manage women's health. It operates through the USA and Australia geographical segments. The firm's product BREVAGenplus, is a clinically validated risk assessment test for non-hereditary breast cancer. The company was founded on January 5, 1987 and is headquartered in Fitzroy, Australia.

Market Capitalization: $13.04M
Prev close: $1.13
Average Daily Volume: 784,831
Days Low: $1.08
Year Low: $1.04
Year High: $2.89

OSCIENT PHARMACEUTICALS CORP Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
May 29 2009GENEOSCIENT PHARMACEUT ...BB BIOVENTURES L P10% OwnerBuyC1.104,2224,6444,2220 to 4.2 K
May 26 2009GENEOSCIENT PHARMACEUT ...GLG Partners LP10% OwnerSellS0.30785,616236,94273,923859.5 K to 73.9 K (-91.40 %)
May 15 2009GENEOSCIENT PHARMACEUT ...DellaCamera Capital Management ...10% OwnerSellS0.21468,23098,1410468.2 K to 0 (-100.00 %)
May 15 2009GENEOSCIENT PHARMACEUT ...DellaCamera Capital Management ...10% OwnerSellS0.23108,16224,921468,230576.4 K to 468.2 K (-18.77 %)
May 15 2009GENEOSCIENT PHARMACEUT ...DellaCamera Capital Management ...10% OwnerSellS0.25416,391104,473576,392992.8 K to 576.4 K (-41.94 %)
May 13 2009GENEOSCIENT PHARMACEUT ...DellaCamera Capital Management ...10% OwnerBuyC0.00992,7830992,7830 to 992.8 K
May 12 2009GENEOSCIENT PHARMACEUT ...DellaCamera Capital Management ...10% OwnerSellS0.27100,32527,4090100.3 K to 0 (-100.00 %)
Apr 01 2009GENEOSCIENT PHARMACEUT ...DellaCamera Capital Management ...10% OwnerSellS0.1370,0008,897100,325170.3 K to 100.3 K (-41.10 %)
Apr 01 2009GENEOSCIENT PHARMACEUT ...DellaCamera Capital Management ...10% OwnerSellS0.13150,00019,065170,325320.3 K to 170.3 K (-46.83 %)
Mar 27 2009GENEOSCIENT PHARMACEUT ...DellaCamera Capital Management ...10% OwnerSellS0.13200,00026,040320,325520.3 K to 320.3 K (-38.44 %)
Mar 27 2009GENEOSCIENT PHARMACEUT ...DellaCamera Capital Management ...10% OwnerSellS0.13160,26920,162520,325680.6 K to 520.3 K (-23.55 %)
Mar 27 2009GENEOSCIENT PHARMACEUT ...DellaCamera Capital Management ...10% OwnerSellS0.18967,939178,682680,5941.6 M to 680.6 K (-58.72 %)
Jul 30 2008GENEOSCIENT PHARMACEUT ...Glickman Mark ASVP, Sales & Market ...Option ExerciseA1.4815,00022,12515,000
Jul 30 2008GENEOSCIENT PHARMACEUT ...Glickman Mark ASVP, Sales & Market ...GrantA0.0010,000036,15726.2 K to 36.2 K (+38.23 %)
Jun 13 2008GENEOSCIENT PHARMACEUT ...BROWN GREGORY BDirectorOption ExerciseA1.777501,328750

View all OSCIENT PHARMACEUTICALS CORP insider transactions.